Counterfeiting, fraud, and theft within the pharmaceutical industry's supply chain
ranges from conservative estimates of $30 billion to more than $50 billion in
annual losses to corporations, according to market studies by PIRA International,
IMS Health, and the U.S. Food & Drug Administration (FDA). The FDA and
pharmaceutical industry groups are calling for devices that minimize counterfeits,
curb abuse and improve patient compliance. ViaNase IDTM
addresses all three requirements.
With built-in electronics and power, ViaNase ID includes the following features:
- Authentication ViaNase ID can recognize specific drug information such as product identification, expiration date, etc. by reading a coding technology placed on the drug packaging or unit dose ampoule. Based on the information read, ViaNase sets operational parameters.
- Lockout control ViaNase ID will power up only if it reads the correct product ID and the drug is not past its expiration date.
- Designated user control ViaNase ID will power up only if it recognizes a permitted caregiver or parent identification code.
- Operational parameter control - Based on drug type, the following variable parameters are set:
- Optimized droplet size and atomization rate
- Vortex characteristics
- Breath activation
- Cleaning cycle designated
- Dosing controls - ViaNase ID can increase patient compliance rates by:
- Setting specific atomization time in min/day or number of doses/day
- Setting the total number of doses per prescription
- Sounding an alarm when a dose is required
- Data storage and transmission - Information such as drug ID, drug type,
time/date of doses, total amount of drug delivered, and operating parameter records can
be saved to a data storage card or downloaded to a PC or PDA. This information is useful
for physicians, pharmacies and clinical trial coordinators.